Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
Add more filters










Publication year range
2.
Sci Transl Med ; 12(565)2020 10 14.
Article in English | MEDLINE | ID: mdl-33055246

ABSTRACT

Extracellular vesicles (EVs) derived from various stem cell sources induce cardioprotective effects during ischemia-reperfusion injury (IRI). These have been attributed mainly to the antiapoptotic, proangiogenic, microRNA (miRNA) cargo within the stem cell-derived EVs. However, the mechanisms of EV-mediated endothelial signaling to cardiomyocytes, as well as their therapeutic potential toward ischemic myocardial injury, are not clear. EV content beyond miRNA that may contribute to cardioprotection has not been fully illuminated. This study characterized the protein cargo of human vascular endothelial EVs (EEVs) to identify lead cardioactive proteins and assessed the effect of EEVs on human laminar cardiac tissues (hlCTs) exposed to IRI. We mapped the protein content of human vascular EEVs and identified proteins that were previously associated with cellular metabolism, redox state, and calcium handling, among other processes. Analysis of the protein landscape of human cardiomyocytes revealed corresponding modifications induced by EEV treatment. To assess their human-specific cardioprotection in vitro, we developed a human heart-on-a-chip IRI assay using human stem cell-derived, engineered cardiac tissues. We found that EEVs alleviated cardiac cell death as well as the loss in contractile capacity during and after simulated IRI in an uptake- and dose-dependent manner. Moreover, we found that EEVs increased the respiratory capacity of normoxic cardiomyocytes. These results suggest that vascular EEVs rescue hlCTs exposed to IRI possibly by supplementing injured myocytes with cargo that supports multiple metabolic and salvage pathways and therefore may serve as a multitargeted therapy for IRI.


Subject(s)
Extracellular Vesicles , MicroRNAs , Reperfusion Injury , Apoptosis , Humans , Myocytes, Cardiac
3.
Adv Biosyst ; 4(9): e1900230, 2020 09.
Article in English | MEDLINE | ID: mdl-32744807

ABSTRACT

The functional state of the neurovascular unit (NVU), composed of the blood-brain barrier and the perivasculature that forms a dynamic interface between the blood and the central nervous system (CNS), plays a central role in the control of brain homeostasis and is strongly affected by CNS drugs. Human primary brain microvascular endothelium, astrocyte, pericyte, and neural cell cultures are often used to study NVU barrier functions as well as drug transport and efficacy; however, the proteomic and metabolomic responses of these different cell types are not well characterized. Culturing each cell type separately, using deep coverage proteomic analysis and characterization of the secreted metabolome, as well as measurements of mitochondrial activity, the responses of these cells under baseline conditions and when exposed to the NVU-impairing stimulant methamphetamine (Meth) are analyzed. These studies define the previously unknown metabolic and proteomic profiles of human brain pericytes and lead to improved characterization of the phenotype of each of the NVU cell types as well as cell-specific metabolic and proteomic responses to Meth.


Subject(s)
Metabolome/drug effects , Methamphetamine/pharmacology , Neurons , Pericytes , Proteome/drug effects , Astrocytes/cytology , Astrocytes/drug effects , Brain/blood supply , Brain/cytology , Cells, Cultured , Central Nervous System Stimulants/pharmacology , Endothelial Cells/cytology , Endothelial Cells/drug effects , Humans , Metabolomics , Neurons/cytology , Neurons/drug effects , Pericytes/cytology , Pericytes/drug effects , Proteome/analysis , Proteomics
4.
Nat Biotechnol ; 36(9): 865-874, 2018 10.
Article in English | MEDLINE | ID: mdl-30125269

ABSTRACT

The neurovascular unit (NVU) regulates metabolic homeostasis as well as drug pharmacokinetics and pharmacodynamics in the central nervous system. Metabolic fluxes and conversions over the NVU rely on interactions between brain microvascular endothelium, perivascular pericytes, astrocytes and neurons, making it difficult to identify the contributions of each cell type. Here we model the human NVU using microfluidic organ chips, allowing analysis of the roles of individual cell types in NVU functions. Three coupled chips model influx across the blood-brain barrier (BBB), the brain parenchymal compartment and efflux across the BBB. We used this linked system to mimic the effect of intravascular administration of the psychoactive drug methamphetamine and to identify previously unknown metabolic coupling between the BBB and neurons. Thus, the NVU system offers an in vitro approach for probing transport, efficacy, mechanism of action and toxicity of neuroactive drugs.


Subject(s)
Endothelial Cells/metabolism , Lab-On-A-Chip Devices , Neurons/metabolism , Blood-Brain Barrier/drug effects , Humans , Methamphetamine/pharmacology , Phenotype
5.
Biomaterials ; 166: 96-108, 2018 06.
Article in English | MEDLINE | ID: mdl-29549768

ABSTRACT

Wounds in the fetus can heal without scarring. Consequently, biomaterials that attempt to recapitulate the biophysical and biochemical properties of fetal skin have emerged as promising pro-regenerative strategies. The extracellular matrix (ECM) protein fibronectin (Fn) in particular is believed to play a crucial role in directing this regenerative phenotype. Accordingly, Fn has been implicated in numerous wound healing studies, yet remains untested in its fibrillar conformation as found in fetal skin. Here, we show that high extensional (∼1.2 ×105 s-1) and shear (∼3 ×105 s-1) strain rates in rotary jet spinning (RJS) can drive high throughput Fn fibrillogenesis (∼10 mL/min), thus producing nanofiber scaffolds that are used to effectively enhance wound healing. When tested on a full-thickness wound mouse model, Fn nanofiber dressings not only accelerated wound closure, but also significantly improved tissue restoration, recovering dermal and epidermal structures as well as skin appendages and adipose tissue. Together, these results suggest that bioprotein nanofiber fabrication via RJS could set a new paradigm for enhancing wound healing and may thus find use in a variety of regenerative medicine applications.


Subject(s)
Biocompatible Materials , Fibronectins , Nanofibers , Wound Healing , Administration, Cutaneous , Animals , Biocompatible Materials/chemistry , Fibronectins/administration & dosage , Male , Mice , Mice, Inbred C57BL , Nanofibers/chemistry , Skin/drug effects , Skin/pathology , Tissue Engineering/methods , Tissue Scaffolds/chemistry , Wound Healing/drug effects
6.
PLoS One ; 13(3): e0194706, 2018.
Article in English | MEDLINE | ID: mdl-29590169

ABSTRACT

Cardiac tissue development and pathology have been shown to depend sensitively on microenvironmental mechanical factors, such as extracellular matrix stiffness, in both in vivo and in vitro systems. We present a novel quantitative approach to assess cardiac structure and function by extending the classical traction force microscopy technique to tissue-level preparations. Using this system, we investigated the relationship between contractile proficiency and metabolism in neonate rat ventricular myocytes (NRVM) cultured on gels with stiffness mimicking soft immature (1 kPa), normal healthy (13 kPa), and stiff diseased (90 kPa) cardiac microenvironments. We found that tissues engineered on the softest gels generated the least amount of stress and had the smallest work output. Conversely, cardiomyocytes in tissues engineered on healthy- and disease-mimicking gels generated significantly higher stresses, with the maximal contractile work measured in NRVM engineered on gels of normal stiffness. Interestingly, although tissues on soft gels exhibited poor stress generation and work production, their basal metabolic respiration rate was significantly more elevated than in other groups, suggesting a highly ineffective coupling between energy production and contractile work output. Our novel platform can thus be utilized to quantitatively assess the mechanotransduction pathways that initiate tissue-level structural and functional remodeling in response to substrate stiffness.


Subject(s)
Mechanotransduction, Cellular , Microscopy, Atomic Force/methods , Myocytes, Cardiac/cytology , Myocytes, Cardiac/physiology , Stress, Mechanical , Tissue Engineering/methods , Animals , Animals, Newborn , Cells, Cultured , Rats , Rats, Sprague-Dawley
7.
Biofabrication ; 10(2): 025004, 2018 01 16.
Article in English | MEDLINE | ID: mdl-29337695

ABSTRACT

Organ-on-chip platforms aim to improve preclinical models for organ-level responses to novel drug compounds. Heart-on-a-chip assays in particular require tissue engineering techniques that rely on labor-intensive photolithographic fabrication or resolution-limited 3D printing of micropatterned substrates, which limits turnover and flexibility of prototyping. We present a rapid and automated method for large scale on-demand micropatterning of gelatin hydrogels for organ-on-chip applications using a novel biocompatible laser-etching approach. Fast and automated micropatterning is achieved via photosensitization of gelatin using riboflavin-5'phosphate followed by UV laser-mediated photoablation of the gel surface in user-defined patterns only limited by the resolution of the 15 µm wide laser focal point. Using this photopatterning approach, we generated microscale surface groove and pillar structures with feature dimensions on the order of 10-30 µm. The standard deviation of feature height was 0.3 µm, demonstrating robustness and reproducibility. Importantly, the UV-patterning process is non-destructive and does not alter gelatin micromechanical properties. Furthermore, as a quality control step, UV-patterned heart chip substrates were seeded with rat or human cardiac myocytes, and we verified that the resulting cardiac tissues achieved structural organization, contractile function, and long-term viability comparable to manually patterned gelatin substrates. Start-to-finish, UV-patterning shortened the time required to design and manufacture micropatterned gelatin substrates for heart-on-chip applications by up to 60% compared to traditional lithography-based approaches, providing an important technological advance enroute to automated and continuous manufacturing of organ-on-chips.


Subject(s)
Hydrogels/chemistry , Tissue Array Analysis/instrumentation , Tissue Engineering/instrumentation , Tissue Scaffolds/chemistry , Animals , Automation , Cells, Cultured , Gelatin/chemistry , Humans , Myocytes, Cardiac/cytology , Printing, Three-Dimensional , Rats
8.
Nat Biomed Eng ; 2(12): 930-941, 2018 12.
Article in English | MEDLINE | ID: mdl-31015723

ABSTRACT

Laboratory studies of the heart use cell and tissue cultures to dissect heart function yet rely on animal models to measure pressure and volume dynamics. Here, we report tissue-engineered scale models of the human left ventricle, made of nanofibrous scaffolds that promote native-like anisotropic myocardial tissue genesis and chamber-level contractile function. Incorporating neonatal rat ventricular myocytes or cardiomyocytes derived from human induced pluripotent stem cells, the tissue-engineered ventricles have a diastolic chamber volume of ~500 µl (comparable to that of the native rat ventricle and approximately 1/250 the size of the human ventricle), and ejection fractions and contractile work 50-250 times smaller and 104-108 times smaller than the corresponding values for rodent and human ventricles, respectively. We also measured tissue coverage and alignment, calcium-transient propagation and pressure-volume loops in the presence or absence of test compounds. Moreover, we describe an instrumented bioreactor with ventricular-assist capabilities, and provide a proof-of-concept disease model of structural arrhythmia. The model ventricles can be evaluated with the same assays used in animal models and in clinical settings.


Subject(s)
Heart Ventricles/cytology , Models, Biological , Tissue Engineering , Animals , Arrhythmias, Cardiac/pathology , Computer-Aided Design , Extracellular Matrix/chemistry , Humans , Induced Pluripotent Stem Cells/cytology , Induced Pluripotent Stem Cells/metabolism , Myocardial Contraction , Myocytes, Cardiac/cytology , Myocytes, Cardiac/metabolism , Nanofibers/chemistry , Polymers/chemistry , Rats , Rats, Sprague-Dawley , Tissue Scaffolds/chemistry , Ventricular Function
9.
Biomaterials ; 133: 229-241, 2017 07.
Article in English | MEDLINE | ID: mdl-28445803

ABSTRACT

Tissue engineered scaffolds have emerged as a promising solution for heart valve replacement because of their potential for regeneration. However, traditional heart valve tissue engineering has relied on resource-intensive, cell-based manufacturing, which increases cost and hinders clinical translation. To overcome these limitations, in situ tissue engineering approaches aim to develop scaffold materials and manufacturing processes that elicit endogenous tissue remodeling and repair. Yet despite recent advances in synthetic materials manufacturing, there remains a lack of cell-free, automated approaches for rapidly producing biomimetic heart valve scaffolds. Here, we designed a jet spinning process for the rapid and automated fabrication of fibrous heart valve scaffolds. The composition, multiscale architecture, and mechanical properties of the scaffolds were tailored to mimic that of the native leaflet fibrosa and assembled into three dimensional, semilunar valve structures. We demonstrated controlled modulation of these scaffold parameters and show initial biocompatibility and functionality in vitro. Valves were minimally-invasively deployed via transapical access to the pulmonary valve position in an ovine model and shown to be functional for 15 h.


Subject(s)
Biocompatible Materials , Biomimetics/methods , Heart Valves/surgery , Tissue Scaffolds , Animals , Heart Valve Prosthesis , Nanofibers , Sheep , Tissue Engineering/methods
10.
Exp Biol Med (Maywood) ; 242(17): 1643-1656, 2017 11.
Article in English | MEDLINE | ID: mdl-28343439

ABSTRACT

In vitro studies of cardiac physiology and drug response have traditionally been performed on individual isolated cardiomyocytes or isotropic monolayers of cells that may not mimic desired physiological traits of the laminar adult myocardium. Recent studies have reported a number of advances to Heart-on-a-Chip platforms for the fabrication of more sophisticated engineered myocardium, but cardiomyocyte immaturity remains a challenge. In the anisotropic musculature of the heart, interactions between cardiac myocytes, the extracellular matrix (ECM), and neighboring cells give rise to changes in cell shape and tissue architecture that have been implicated in both development and disease. We hypothesized that engineered myocardium fabricated from cardiac myocytes cultured in vitro could mimic the physiological characteristics and gene expression profile of adult heart muscle. To test this hypothesis, we fabricated engineered myocardium comprised of neonatal rat ventricular myocytes with laminar architectures reminiscent of that observed in the mature heart and compared their sarcomere organization, contractile performance characteristics, and cardiac gene expression profile to that of isolated adult rat ventricular muscle strips. We found that anisotropic engineered myocardium demonstrated a similar degree of global sarcomere alignment, contractile stress output, and inotropic concentration-response to the ß-adrenergic agonist isoproterenol. Moreover, the anisotropic engineered myocardium exhibited comparable myofibril related gene expression to muscle strips isolated from adult rat ventricular tissue. These results suggest that tissue architecture serves an important developmental cue for building in vitro model systems of the myocardium that could potentially recapitulate the physiological characteristics of the adult heart. Impact statement With the recent focus on developing in vitro Organ-on-Chip platforms that recapitulate tissue and organ-level physiology using immature cells derived from stem cell sources, there is a strong need to assess the ability of these engineered tissues to adopt a mature phenotype. In the present study, we compared and contrasted engineered tissues fabricated from neonatal rat ventricular myocytes in a Heart-on-a-Chip platform to ventricular muscle strips isolated from adult rats. The results of this study support the notion that engineered tissues fabricated from immature cells have the potential to mimic mature tissues in an Organ-on-Chip platform.


Subject(s)
Heart Ventricles/cytology , Microchip Analytical Procedures/methods , Myocytes, Cardiac/cytology , Myocytes, Cardiac/physiology , Tissue Engineering/methods , Ventricular Function/physiology , Animals , Cell Differentiation , Cells, Cultured , Gene Expression Profiling , Lab-On-A-Chip Devices , Myocardial Contraction/physiology , Rats , Rats, Sprague-Dawley
11.
Biomaterials ; 122: 48-62, 2017 04.
Article in English | MEDLINE | ID: mdl-28107664

ABSTRACT

To date, clinical success of cardiac cell-therapies remains limited. To enhance the cardioreparative properties of stem cells, the concept of lineage-specification through cardiopoietic-guidance has been recently suggested. However, so far, only results from murine studies and from a clinical pilot-trial in chronic heart-failure (CHF) are available, while systematic evidence of its therapeutic-efficacy is still lacking. Importantly, also no data from large animals or for other indications are available. Therefore, we here investigate the therapeutic-efficacy of human cardiopoietic stem cells in the treatment of post-infarction LV-dysfunction using a translational pig-model. Using growth-factor priming, lineage-specification of human bone-marrow derived MSCs was achieved to generate cardiopoietic stem cells according to GMP-compliant protocols. Thereafter, pigs with post-infarction LV-dysfunction (sub-acute phase;1-month) were randomized to either receive transcatheter NOGA 3D electromechanical-mapping guided intramyocardial transplantation of cardiopoietic cells or saline (control). After 30days, cardiac MRI (cMRI) was performed for functional evaluation and in-vivo cell-tracking. This approach was coupled with a comprehensive post-mortem cell-fate and mode-of-repair analysis. Cardiopoietic cell therapy was safe and ejection-fraction was significantly higher when compared to controls (p = 0.012). It further prevented maladaptive LV-remodeling and revealed a significantly lower relative and total infarct-size (p = 0.043 and p = 0.012). As in-vivo tracking and post-mortem analysis displayed only limited intramyocardial cardiopoietic cell-integration, the significant induction of neo-angiogenesis (∼40% higher; p = 0.003) and recruitment of endogenous progenitors (∼2.5x higher; p = 0.008) to the infarct border-zone appeared to be the major modes-of-repair. This is the first report using a pre-clinical large animal-model to demonstrate the safety and efficacy of cardiopoietic stem cells for the treatment of post-infarction LV-dysfunction to prevent negative LV-remodeling and subsequent CHF. It further provides insight into post-delivery cardiopoietic cell-fate and suggests the mechanisms of cardiopoietic cell-induced cardiac-repair. The adoption of GMP-/GLP-compliant methodologies may accelerate the translation into a phase-I clinical-trial in patients with post-ischemic LV-dysfunction broadening the current indication of this interesting cell-type.


Subject(s)
Mesenchymal Stem Cell Transplantation/methods , Myocardial Infarction/physiopathology , Myocardial Infarction/therapy , Ventricular Dysfunction, Left/physiopathology , Ventricular Dysfunction, Left/therapy , Animals , Mesenchymal Stem Cell Transplantation/adverse effects , Myocardial Infarction/complications , Recovery of Function , Swine , Treatment Outcome , Ventricular Dysfunction, Left/etiology , Ventricular Remodeling
12.
J Neurophysiol ; 117(3): 1320-1341, 2017 03 01.
Article in English | MEDLINE | ID: mdl-28031399

ABSTRACT

Brain in vitro models are critically important to developing our understanding of basic nervous system cellular physiology, potential neurotoxic effects of chemicals, and specific cellular mechanisms of many disease states. In this study, we sought to address key shortcomings of current brain in vitro models: the scarcity of comparative data for cells originating from distinct brain regions and the lack of multiregional brain in vitro models. We demonstrated that rat neurons from different brain regions exhibit unique profiles regarding their cell composition, protein expression, metabolism, and electrical activity in vitro. In vivo, the brain is unique in its structural and functional organization, and the interactions and communication between different brain areas are essential components of proper brain function. This fact and the observation that neurons from different areas of the brain exhibit unique behaviors in vitro underline the importance of establishing multiregional brain in vitro models. Therefore, we here developed a multiregional brain-on-a-chip and observed a reduction of overall firing activity, as well as altered amounts of astrocytes and specific neuronal cell types compared with separately cultured neurons. Furthermore, this multiregional model was used to study the effects of phencyclidine, a drug known to induce schizophrenia-like symptoms in vivo, on individual brain areas separately while monitoring downstream effects on interconnected regions. Overall, this work provides a comparison of cells from different brain regions in vitro and introduces a multiregional brain-on-a-chip that enables the development of unique disease models incorporating essential in vivo features.NEW & NOTEWORTHY Due to the scarcity of comparative data for cells from different brain regions in vitro, we demonstrated that neurons isolated from distinct brain areas exhibit unique behaviors in vitro. Moreover, in vivo proper brain function is dependent on the connection and communication of several brain regions, underlining the importance of developing multiregional brain in vitro models. We introduced a novel brain-on-a-chip model, implementing essential in vivo features, such as different brain areas and their functional connections.


Subject(s)
Brain/anatomy & histology , Brain/cytology , Neurons/classification , Neurons/physiology , Action Potentials/physiology , Analysis of Variance , Animals , Animals, Newborn , Astrocytes/metabolism , Cells, Cultured , Chromatography, High Pressure Liquid , Female , Gene Expression/physiology , Glutamate Decarboxylase/metabolism , Hallucinogens/pharmacology , Male , Nerve Tissue Proteins/metabolism , Neurons/drug effects , Oxygen Consumption , Phencyclidine/pharmacology , Principal Component Analysis , Protein Interaction Maps , Rats , Rats, Sprague-Dawley , Tandem Mass Spectrometry , Vesicular Glutamate Transport Protein 1/metabolism
13.
J Cell Biol ; 212(4): 389-97, 2016 Feb 15.
Article in English | MEDLINE | ID: mdl-26858266

ABSTRACT

The efficacy of cardiac cell therapy depends on the integration of existing and newly formed cardiomyocytes. Here, we developed a minimal in vitro model of this interface by engineering two cell microtissues (µtissues) containing mouse cardiomyocytes, representing spared myocardium after injury, and cardiomyocytes generated from embryonic and induced pluripotent stem cells, to model newly formed cells. We demonstrated that weaker stem cell-derived myocytes coupled with stronger myocytes to support synchronous contraction, but this arrangement required focal adhesion-like structures near the cell-cell junction that degrade force transmission between cells. Moreover, we developed a computational model of µtissue mechanics to demonstrate that a reduction in isometric tension is sufficient to impair force transmission across the cell-cell boundary. Together, our in vitro and in silico results suggest that mechanotransductive mechanisms may contribute to the modest functional benefits observed in cell-therapy studies by regulating the amount of contractile force effectively transmitted at the junction between newly formed and spared myocytes.


Subject(s)
Cell Communication , Myocardial Contraction , Myocytes, Cardiac/physiology , Stem Cells/physiology , Tissue Engineering/methods , Animals , Animals, Newborn , Calcium/metabolism , Cell Differentiation , Cells, Cultured , Computer Simulation , Focal Adhesions/metabolism , Mechanotransduction, Cellular , Mice , Mice, Inbred BALB C , Models, Cardiovascular , Myocytes, Cardiac/transplantation , Phenotype , Primary Cell Culture , Stem Cell Transplantation , Stress, Mechanical , Time Factors
14.
PLoS One ; 11(1): e0146415, 2016.
Article in English | MEDLINE | ID: mdl-26808388

ABSTRACT

In vitro disease models offer the ability to study specific systemic features in isolation to better understand underlying mechanisms that lead to dysfunction. Here, we present a cardiac dysfunction model using angiotensin II (ANG II) to elicit pathological responses in a heart-on-a-chip platform that recapitulates native laminar cardiac tissue structure. Our platform, composed of arrays of muscular thin films (MTF), allows for functional comparisons of healthy and diseased tissues by tracking film deflections resulting from contracting tissues. To test our model, we measured gene expression profiles, morphological remodeling, calcium transients, and contractile stress generation in response to ANG II exposure and compared against previous experimental and clinical results. We found that ANG II induced pathological gene expression profiles including over-expression of natriuretic peptide B, Rho GTPase 1, and T-type calcium channels. ANG II exposure also increased proarrhythmic early after depolarization events and significantly reduced peak systolic stresses. Although ANG II has been shown to induce structural remodeling, we control tissue architecture via microcontact printing, and show pathological genetic profiles and functional impairment precede significant morphological changes. We assert that our in vitro model is a useful tool for evaluating tissue health and can serve as a platform for studying disease mechanisms and identifying novel therapeutics.


Subject(s)
Angiotensin II/pharmacology , Gene Expression/drug effects , Myocytes, Cardiac/drug effects , Ventricular Remodeling/drug effects , Animals , Gene Expression Profiling , Models, Theoretical , Myocardial Contraction/drug effects , Myocardium/metabolism , Myocytes, Cardiac/metabolism , Rats
15.
Biomed Res Int ; 2016: 4081638, 2016.
Article in English | MEDLINE | ID: mdl-28044126

ABSTRACT

Efficient contractions of the left ventricle are ensured by the continuous transfer of adenosine triphosphate (ATP) from energy production sites, the mitochondria, to energy utilization sites, such as ionic pumps and the force-generating sarcomeres. To minimize the impact of intracellular ATP trafficking, sarcomeres and mitochondria are closely packed together and in proximity with other ultrastructures involved in excitation-contraction coupling, such as t-tubules and sarcoplasmic reticulum junctions. This complex microdomain has been referred to as the intracellular energetic unit. Here, we review the literature in support of the notion that cardiac homeostasis and disease are emergent properties of the hierarchical organization of these units. Specifically, we will focus on pathological alterations of this microdomain that result in cardiac diseases through energy imbalance and posttranslational modifications of the cytoskeletal proteins involved in mechanosensing and transduction.


Subject(s)
Mechanotransduction, Cellular/physiology , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/physiology , Animals , Energy Metabolism/physiology , Excitation Contraction Coupling/physiology , Heart Ventricles/metabolism , Heart Ventricles/physiopathology , Humans , Mitochondria/metabolism , Mitochondria/physiology , Protein Processing, Post-Translational/physiology , Sarcoplasmic Reticulum/physiology
16.
Adv Drug Deliv Rev ; 96: 83-102, 2016 Jan 15.
Article in English | MEDLINE | ID: mdl-26656602

ABSTRACT

Extracellular matrix (ECM) structure and biochemistry provide cell-instructive cues that promote and regulate tissue growth, function, and repair. From a structural perspective, the ECM is a scaffold that guides the self-assembly of cells into distinct functional tissues. The ECM promotes the interaction between individual cells and between different cell types, and increases the strength and resilience of the tissue in mechanically dynamic environments. From a biochemical perspective, factors regulating cell-ECM adhesion have been described and diverse aspects of cell-ECM interactions in health and disease continue to be clarified. Natural ECMs therefore provide excellent design rules for tissue engineering scaffolds. The design of regenerative three-dimensional (3D) engineered scaffolds is informed by the target ECM structure, chemistry, and mechanics, to encourage cell infiltration and tissue genesis. This can be achieved using nanofibrous scaffolds composed of polymers that simultaneously recapitulate 3D ECM architecture, high-fidelity nanoscale topography, and bio-activity. Their high porosity, structural anisotropy, and bio-activity present unique advantages for engineering 3D anisotropic tissues. Here, we use the heart as a case study and examine the potential of ECM-inspired nanofibrous scaffolds for cardiac tissue engineering. We asked: Do we know enough to build a heart? To answer this question, we tabulated structural and functional properties of myocardial and valvular tissues for use as design criteria, reviewed nanofiber manufacturing platforms and assessed their capabilities to produce scaffolds that meet our design criteria. Our knowledge of the anatomy and physiology of the heart, as well as our ability to create synthetic ECM scaffolds have advanced to the point that valve replacement with nanofibrous scaffolds may be achieved in the short term, while myocardial repair requires further study in vitro and in vivo.


Subject(s)
Heart Valves/cytology , Heart Ventricles/cytology , Myocardium/cytology , Nanofibers/chemistry , Tissue Engineering/methods , Tissue Scaffolds/chemistry , Animals , Biomechanical Phenomena , Heart Conduction System , Heart Valves/physiopathology , Heart Ventricles/physiopathology , Humans , Myocardial Contraction
17.
Exp Biol Med (Maywood) ; 240(11): 1543-54, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25908635

ABSTRACT

Mechanical stresses on the myocyte nucleus have been associated with several diseases and potentially transduce mechanical stimuli into cellular responses. Although a number of physical links between the nuclear envelope and cytoplasmic filaments have been identified, previous studies have focused on the mechanical properties of individual components of the nucleus, such as the nuclear envelope and lamin network. The mechanical interaction between the cytoskeleton and chromatin on nuclear deformability remains elusive. Here, we investigated how cytoskeletal and chromatin structures influence nuclear mechanics in cardiac myocytes. Rapid decondensation of chromatin and rupture of the nuclear membrane caused a sudden expansion of DNA, a consequence of prestress exerted on the nucleus. To characterize the prestress exerted on the nucleus, we measured the shape and the stiffness of isolated nuclei and nuclei in living myocytes during disruption of cytoskeletal, myofibrillar, and chromatin structure. We found that the nucleus in myocytes is subject to both tensional and compressional prestress and its deformability is determined by a balance of those opposing forces. By developing a computational model of the prestressed nucleus, we showed that cytoskeletal and chromatin prestresses create vulnerability in the nuclear envelope. Our studies suggest the cytoskeletal-nuclear-chromatin interconnectivity may play an important role in mechanics of myocyte contraction and in the development of laminopathies by lamin mutations.


Subject(s)
Cell Nucleus/metabolism , Cytoskeleton/metabolism , Myocytes, Cardiac/cytology , Animals , Animals, Newborn , Chromatin/metabolism , Compressive Strength , DNA/chemistry , Extracellular Matrix/metabolism , Finite Element Analysis , Microscopy, Atomic Force , Microscopy, Confocal , Microscopy, Fluorescence , Myocardial Contraction , Nuclear Envelope/metabolism , Rats , Rats, Sprague-Dawley , Stress, Mechanical
18.
Stem Cell Reports ; 2(3): 282-94, 2014 Mar 11.
Article in English | MEDLINE | ID: mdl-24672752

ABSTRACT

Advances in stem cell manufacturing methods have made it possible to produce stem cell-derived cardiac myocytes at industrial scales for in vitro muscle physiology research purposes. Although FDA-mandated quality assurance metrics address safety issues in the manufacture of stem cell-based products, no standardized guidelines currently exist for the evaluation of stem cell-derived myocyte functionality. As a result, it is unclear whether the various stem cell-derived myocyte cell lines on the market perform similarly, or whether any of them accurately recapitulate the characteristics of native cardiac myocytes. We propose a multiparametric quality assessment rubric in which genetic, structural, electrophysiological, and contractile measurements are coupled with comparison against values for these measurements that are representative of the ventricular myocyte phenotype. We demonstrated this procedure using commercially available, mass-produced murine embryonic stem cell- and induced pluripotent stem cell-derived myocytes compared with a neonatal mouse ventricular myocyte target phenotype in coupled in vitro assays.


Subject(s)
Cell Culture Techniques , Extracellular Matrix , Myocytes, Cardiac/cytology , Stem Cells/cytology , Animals , Animals, Newborn , Cells, Cultured , Cluster Analysis , Electrophysiological Phenomena , Embryonic Stem Cells/cytology , Embryonic Stem Cells/metabolism , Gene Expression Profiling , Guided Tissue Regeneration , Induced Pluripotent Stem Cells/cytology , Induced Pluripotent Stem Cells/metabolism , Mice , Myocardial Contraction , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/ultrastructure , Myofibrils/metabolism , Phenotype , Sarcomeres/metabolism , Stem Cells/metabolism
19.
J R Soc Interface ; 11(93): 20130942, 2014 Apr 06.
Article in English | MEDLINE | ID: mdl-24478280

ABSTRACT

Cuttlefish, Sepia officinalis, possess neurally controlled, pigmented chromatophore organs that allow rapid changes in skin patterning and coloration in response to visual cues. This process of adaptive coloration is enabled by the 500% change in chromatophore surface area during actuation. We report two adaptations that help to explain how colour intensity is maintained in a fully expanded chromatophore when the pigment granules are distributed maximally: (i) pigment layers as thin as three granules that maintain optical effectiveness and (ii) the presence of high-refractive-index proteins-reflectin and crystallin-in granules. The latter discovery, combined with our finding that isolated chromatophore pigment granules fluoresce between 650 and 720 nm, refutes the prevailing hypothesis that cephalopod chromatophores are exclusively pigmentary organs composed solely of ommochromes. Perturbations to granular architecture alter optical properties, illustrating a role for nanostructure in the agile, optical responses of chromatophores. Our results suggest that cephalopod chromatophore pigment granules are more complex than homogeneous clusters of chromogenic pigments. They are luminescent protein nanostructures that facilitate the rapid and sophisticated changes exhibited in dermal pigmentation.


Subject(s)
Chromatophores , Decapodiformes , Pigments, Biological/metabolism , Skin Pigmentation/physiology , Animals , Chromatophores/cytology , Chromatophores/metabolism , Decapodiformes/anatomy & histology , Decapodiformes/physiology
20.
Stem Cell Reports ; 1(5): 387-96, 2013.
Article in English | MEDLINE | ID: mdl-24286027

ABSTRACT

Stem cell-derived cardiomyocytes represent unique tools for cell- and tissue-based regenerative therapies, drug discovery and safety, and studies of fundamental heart-failure mechanisms. However, the degree to which stem cell-derived cardiomyocytes compare to mature cardiomyocytes is often debated. We reasoned that physiological metrics of engineered cardiac tissues offer a means of comparison. We built laminar myocardium engineered from cardiomyocytes that were differentiated from mouse embryonic stem cell-derived cardiac progenitors or harvested directly from neonatal mouse ventricles, and compared their anatomy and physiology in vitro. Tissues assembled from progenitor-derived myocytes and neonate myocytes demonstrated similar cytoskeletal architectures but different gap junction organization and electromechanical properties. Progenitor-derived myocardium had significantly less contractile stress and slower longitudinal conduction velocity than neonate-derived myocardium, indicating that the developmental state of the cardiomyocytes affects the electromechanical function of the resultant engineered tissue. These data suggest a need to establish performance metrics for future stem cell applications.


Subject(s)
Action Potentials , Cell Differentiation , Embryonic Stem Cells/cytology , Heart Ventricles/cytology , Myocardial Contraction , Myocytes, Cardiac/physiology , Actin Cytoskeleton/metabolism , Animals , Cells, Cultured , Embryonic Stem Cells/metabolism , Embryonic Stem Cells/physiology , Heart Ventricles/embryology , Intercellular Junctions/metabolism , Mice , Mice, Inbred C57BL , Myocytes, Cardiac/cytology , Myocytes, Cardiac/metabolism , Tissue Engineering
SELECTION OF CITATIONS
SEARCH DETAIL
...